目的 分析早、中期肝细胞癌（HCC）切除术后早期（≤2年）复发的危险因素并探讨术前系统免疫炎症指数（SII）对早、中期HCC术后早期复发的预测价值。方法 回顾性研究2017年10月—2020年10月于我院接受肝癌根治性切除术的238例早中期HCC患者,收集基线资料,通过1∶1倾向性评分匹配（PSM）均衡组间协变量获取早期复发组及未复发组各69例;单因素和多因素Logistic回归分析影响术后早期HCC复发的相关因素,构建列线图模型,临床决策曲线（DCA）评估列线图预测模型在临床的应用效果;受试者操作特征（ROC）曲线评价预测效能,根据最高约登指数确定截断点。结果 单因素及多因素Logistic回归分析结果均提示微血管侵犯（MVI）及术前系统免疫炎症指数（SII）高水平是术后早期复发的独立危险因素;列线图模型有较好的预测效能;ROC曲线计算出SII最佳临界值为696.85×10⁹／L。结论 术前高水平SII可能对预测HCC患者术后早期复发具有潜在价值。

目的 探讨经阴道三维容积超声成像在诊断子宫肌瘤FIGO分类的临床应用价值。方法 对本院收治的手术病理结果证实的219例子宫肌瘤,回顾临床资料分组,99例以经阴道三维容积超声成像作为观察组,120例以经阴道二维彩超检查作为对照组。评估经阴道三维容积超声成像在诊断子宫肌瘤FIGO分类的诊断符合率。结果 两组子宫肌瘤FIGO分类诊断符合率分别为:观察组97.93%,对照组78.33%;经阴道三维容积超声成像检查诊断符合率显著高于二维彩超,差异有统计学意义。结论 经阴道三维容积超声成像较二维彩超能获得更为丰富的诊断信息,诊断子宫肌瘤FIGO分类较二维彩超优势显著,有利于提高诊断准确率,为指导临床个性化治疗提供可靠的理论依据,值得临床推广应用。

Objective To investigate the clinical value of transvaginal three-dimensional volumetric ultrasound imaging in the diagnosis of the FIGO classification of hysteromyoma. Methods To retrospectively analysis data of 219 cases hysteromyoma confirmed by the surgical pathological findings in this hospital. 99 cases treated with transvaginal 3D ultrasound were as the observation group, and 120 cases treated with vaginal 2D ultrasound as the control group. To evaluate the diagnostic coincidence rate of transvaginal three-dimensional volumetric ultrasound imaging in the diagnosis of FIGO classification of hysteromyoma. Results The coincidence rates of FIGO classification of hysteromyoma in the two groups were 97.93% in the observation group and 78.33% in the control group; the diagnostic coincidence rate of transvaginal three-dimensional volumetric ultrasound imaging was higher than that of two-dimensional color Doppler ultrasound, and the difference was statistically significant. Conclusion Transvaginal three-dimensional volumetric ultrasound imaging can obtain richer diagnostic information than two-dimensional color Doppler ultrasound. In the FIGO classification of hysteromyoma, it has significant advantages than two-dimensional color Doppler ultrasound, which is conducive to improving the diagnostic accuracy and providing a reliable theory for guiding clinical personalized treatment. The basis is worthy of clinical promotion and application.